BIOMAT Database Logo BIOMAT Database Logo

[Beta-adrenergic inhibition of adrenaline effects on some coagulative and fibrinolytic parameters]. 1971

M Cornia, and I Spagna, and E Bonavita, and F Tabarroni, and D Spagnolo, and C Fabbri, and A Di Taranto

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic

Related Publications

M Cornia, and I Spagna, and E Bonavita, and F Tabarroni, and D Spagnolo, and C Fabbri, and A Di Taranto
[Activity of mucopolysaccharide extract on some coagulative and fibrinolytic parameters and on platelet aggregation tests].
April 1979, Giornale di clinica medica,
M Cornia, and I Spagna, and E Bonavita, and F Tabarroni, and D Spagnolo, and C Fabbri, and A Di Taranto
[Heparan sulfate: its kinetic effects on fibrinolytic-coagulative parameters after oral administration].
September 1992, Minerva medica,
M Cornia, and I Spagna, and E Bonavita, and F Tabarroni, and D Spagnolo, and C Fabbri, and A Di Taranto
[Interrelationship between oral contraceptives and some parameters of the coagulative-fibrinolytic function (author's transl)].
January 1981, Patologia e clinica ostetrica e ginecologica,
M Cornia, and I Spagna, and E Bonavita, and F Tabarroni, and D Spagnolo, and C Fabbri, and A Di Taranto
Effects of some beta-adrenergic blockers on male fertility parameters in rats.
January 1998, DTW. Deutsche tierarztliche Wochenschrift,
M Cornia, and I Spagna, and E Bonavita, and F Tabarroni, and D Spagnolo, and C Fabbri, and A Di Taranto
A comparison of the effects of noradrenaline, adrenaline and some phenylephrine derivatives on alpha-, beta- and beta- adrenergic receptors.
March 1971, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M Cornia, and I Spagna, and E Bonavita, and F Tabarroni, and D Spagnolo, and C Fabbri, and A Di Taranto
Effects of propranolol (a beta adrenergic blocking agent) on some central nervous system parameters.
May 1971, The Indian journal of medical research,
M Cornia, and I Spagna, and E Bonavita, and F Tabarroni, and D Spagnolo, and C Fabbri, and A Di Taranto
[Inhibition of eosinophil decrease after adrenaline by a adrenergic beta-receptor].
January 1967, Klinische Wochenschrift,
M Cornia, and I Spagna, and E Bonavita, and F Tabarroni, and D Spagnolo, and C Fabbri, and A Di Taranto
[Effects of low molecular weight heparin (FR-860) on coagulative and fibrinolytic activities].
October 1989, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
M Cornia, and I Spagna, and E Bonavita, and F Tabarroni, and D Spagnolo, and C Fabbri, and A Di Taranto
Change of lipoprotein (a) and coagulative or fibrinolytic parameters in diabetic patients with nephropathy.
January 1994, Journal of atherosclerosis and thrombosis,
M Cornia, and I Spagna, and E Bonavita, and F Tabarroni, and D Spagnolo, and C Fabbri, and A Di Taranto
Change of lipoprotein(a) and coagulative or fibrinolytic parameters in diabetic patients with nephropathy.
October 1993, Diabetes care,
Copied contents to your clipboard!